BRIEF published on 12/03/2025 at 16:03, 9 months 8 days ago Amundi Index Solutions Announces Annual Dividend Payments Shareholders Investment ETF Dividend Payments Amundi Index Solutions
BRIEF published on 12/03/2025 at 16:03, 9 months 8 days ago Amundi Index Solutions annonce le versement de ses dividendes annuels Investissement Actionnaires ETF Paiements De Dividendes Solutions D'indexation Amundi
PRESS RELEASE published on 12/03/2025 at 15:58, 9 months 8 days ago Amundi Index Solutions: NOTICE TO SHAREHOLDERS (Correction of the news published on 02.12.2025 at 12:54 CET) Amundi Index Solutions informs shareholders about annual dividends distribution for various ETFs on December 11, 2025 Shareholders ETFs Dividends Distribution Amundi Index Solutions
BRIEF published on 12/02/2025 at 12:59, 9 months 10 days ago Amundi Index Solutions Announces Dividend Payments for Shareholders Shareholders ETFs Dividends Amundi Distribution
BRIEF published on 12/02/2025 at 12:59, 9 months 10 days ago Amundi Index Solutions annonce le versement de dividendes à ses actionnaires Actionnaires ETF Dividendes Amundi Distribution
PRESS RELEASE published on 12/02/2025 at 12:54, 9 months 10 days ago Amundi Index Solutions: NOTICE TO SHAREHOLDERS Amundi Index Solutions announces annual dividends distribution for shareholders. Ex-date: December 9, 2025; Payment date: December 11, 2025. Details of ETF dividends included Shareholders ETF Dividends Amundi Index Solutions
BRIEF published on 09/05/2025 at 11:05, 1 year ago Amundi Index Solutions Announces Sub-Fund Name Changes Amundi ETF Investment Policy Sub-fund Name Changes Effective September 2025 Luxembourg Office
BRIEF published on 09/05/2025 at 11:05, 1 year ago Amundi Index Solutions annonce des changements de nom pour ses compartiments Politique D'investissement ETF Amundi Changements De Nom De Sous-fonds En Vigueur À Partir De Septembre 2025 Bureau Du Luxembourg
PRESS RELEASE published on 09/05/2025 at 11:00, 1 year ago Amundi Index Solutions: NOTICE TO SHAREHOLDERS Amundi Index Solutions announces amendment to the Prospectus and Key Investor Documents for harmonization of sub-funds names. Modification effective on 11th September 2025 Prospectus Amendment Amundi Index Solutions Harmonization Key Investor Documents Sub-funds Names
PRESS RELEASE published on 05/10/2023 at 09:29, 3 years 4 months ago Amundi Prime Euro Corporates UCITS ETF DR (D): Net Asset Value(s)
Published on 09/12/2026 at 02:35, 11 hours 45 minutes ago Gamma Resources Announces Extension of Private Placement Closing Date
Published on 09/11/2026 at 23:00, 15 hours 20 minutes ago Rio Grande Resources Engages Machai Capital for Investor Outreach
Published on 09/11/2026 at 22:05, 16 hours 15 minutes ago Usha Resources Announces Leadership Transition
Published on 09/11/2026 at 21:25, 16 hours 55 minutes ago Algo Grande Copper Intersects 30.23 Metres Grading 1.5% CuEq, including 3.55 Metres at 9.4% CuEq and 1.2-Metre Interval at 15.8% CuEq, 100 Metres Vertical Step-Out from Historical Intersects
Published on 09/11/2026 at 17:00, 21 hours 20 minutes ago Critical Elements Selected for Canada Investment Summit Prospectus, Showcasing Project to Leading Global Investors
Published on 09/12/2026 at 07:30, 6 hours 50 minutes ago NAGRAVISION Secures Formula 1 Content for RTL Croatia and PRO PLUS Slovenia
Published on 09/11/2026 at 22:15, 16 hours 5 minutes ago Amrize Appoints Mario Gross as President of Building Envelope
Published on 09/11/2026 at 22:10, 16 hours 10 minutes ago Quantinuum to Participate in the Piper Sandler 5th Annual Growth Frontiers Conference
Published on 09/11/2026 at 19:44, 18 hours 35 minutes ago DocMorris announces final conversion price and issue size of its New Convertible Bonds due 2031
Published on 09/11/2026 at 18:15, 20 hours 5 minutes ago CGTN: How BRICS creates new opportunities for Global South development
Published on 09/11/2026 at 07:00, 1 day 7 hours ago BIOPHYTIS ANNOUNCES COMPLETION OF €5.3 MILLION CAPITAL INCREASE TO FUND ITS PHASE 2 TRIAL IN OBESITY
Published on 09/11/2026 at 07:00, 1 day 7 hours ago BIOPHYTIS ANNONCE LA RÉALISATION D’UNE AUGMENTATION DE CAPITAL DE 5,3 MILLIONS D’EUROS DESTINÉE À FINANCER SON ESSAI DE PHASE 2 DANS L’OBÉSITÉ
Published on 09/10/2026 at 19:30, 1 day 18 hours ago Availability of the 2026 Interim Financial Report
